Literature DB >> 11378269

Distinct hematopoietic support by two human stromal cell lines.

C Loeuillet1, G Bernard, J Rémy-Martin, P Saas, P Hervé, L Douay, D Chalmers.   

Abstract

OBJECTIVE: The hematopoietic microenvironment is complex, and the role of myofibroblast in its function is crucial. In order to obtain a stable model reflecting this particular cell type, we have previously established human bone marrow cell lines from primary myofibroblastic Stro1(+) population (pStro1(+)). We placed HPV16 E6 and E7 expression under the control of different promoters. Here, we have characterized and studied the hematopoietic support for two cell lines corresponding to the promoters alpha-SM (alphaSM-56 line) and SV40 (SV40-56 line).
MATERIALS AND METHODS: The expression profile was analyzed at the RNA level by gene array and at the protein level by Western blot, flow cytometry, and ELISA. Hematopoietic support determined using colony-forming unit (CFU) and stroma-adherent colony-forming cell (SA-CFC) assays.
RESULTS: The phenotype of cell lines was not significantly modified compared with primary myofibroblastic cells. They secreted a broad spectrum of hematopoietic cytokines and nonspecific mediators. The two lines allowed the growth of hematopoietic precursors and had different support capabilities.
CONCLUSIONS: We have extensively characterized two novel human bone marrow stromal cell lines. They retained a myofibroblastic phenotype and have substantial but different hematopoietic support capabilities. These lines provided a basis for determining stromal factors involved in stem-cell regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378269     DOI: 10.1016/s0301-472x(01)00644-0

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

2.  Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin.

Authors:  Qi Feng; Chou Chai; Xue-Song Jiang; Kam W Leong; Hai-Quan Mao
Journal:  J Biomed Mater Res A       Date:  2006-09-15       Impact factor: 4.396

3.  Human olfactory mucosa multipotent mesenchymal stromal cells promote survival, proliferation, and differentiation of human hematopoietic cells.

Authors:  Dylana Diaz-Solano; Olga Wittig; Carlos Ayala-Grosso; Rosalinda Pieruzzini; Jose E Cardier
Journal:  Stem Cells Dev       Date:  2012-05-18       Impact factor: 3.272

4.  Cocultivation of umbilical cord blood CD34+ cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells.

Authors:  Chun-Gang Xie; Jin-Fu Wang; Ying Xiang; Li-Yan Qiu; Bing-Bing Jia; Li-Juan Wang; Guo-Zhong Wang; Guo-Ping Huang
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

5.  SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin.

Authors:  Petra Simic; Kayvan Zainabadi; Eric Bell; David B Sykes; Borja Saez; Sutada Lotinun; Roland Baron; David Scadden; Ernestina Schipani; Leonard Guarente
Journal:  EMBO Mol Med       Date:  2013-01-30       Impact factor: 12.137

6.  Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells.

Authors:  Sara Bucar; André Dargen de Matos Branco; Márcia F Mata; João Coutinho Milhano; Íris Caramalho; Joaquim M S Cabral; Ana Fernandes-Platzgummer; Cláudia L da Silva
Journal:  Stem Cell Res Ther       Date:  2021-07-13       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.